Perinatal Caffeine, Acting on Maternal Adenosine A1 Receptors, Causes Long-Lasting Behavioral Changes in Mouse Offspring

被引:28
作者
Bjorklund, Olga [1 ]
Kahlstrom, Johan [1 ]
Salmi, Peter [1 ]
Fredholm, Bertil B. [1 ]
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
关键词
D O I
10.1371/journal.pone.0003977
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are lingering concerns about caffeine consumption during pregnancy or the early postnatal period, partly because there may be long-lasting behavioral changes after caffeine exposure early in life. Methodology/Principal Findings: We show that pregnant wild type (WT) mice given modest doses of caffeine (0.3 g/l in drinking water) gave birth to offspring that as adults exhibited increased locomotor activity in an open field. The offspring also responded to cocaine challenge with greater locomotor activity than mice not perinatally exposed to caffeine. We performed the same behavioral experiments on mice heterozygous for adenosine A(1) receptor gene (A(1)RHz). In these mice signaling via adenosine A(1) receptors is reduced to about the same degree as after modest consumption of caffeine. A(1)RHz mice had a behavioral profile similar to WT mice perinatally exposed to caffeine. Furthermore, it appeared that the mother's genotype, not offspring's, was critical for behavioral changes in adult offspring. Thus, if the mother partially lacked A(1) receptors the offspring displayed more hyperactivity and responded more strongly to cocaine stimulation as adults than did mice of a WT mother, regardless of their genotype. This indicates that long-term behavioral alterations in the offspring result from the maternal effect of caffeine, and not a direct effect on fetus. WT offspring from WT mother but having a A(1)R Hz grandmother preserved higher locomotor response to cocaine. Conclusions/Significance: We suggest that perinatal caffeine, by acting on adenosine A(1) receptors in the mother, causes long-lasting behavioral changes in the offspring that even manifest themselves in the second generation.
引用
收藏
页数:11
相关论文
共 50 条
[11]  
El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170
[12]  
Feldman R., 1997, Principles of Neuropharmacology
[13]   Adenosine A1-A2A receptor heteromers:: new targets for caffeine in the brain [J].
Ferre, Sergi ;
Ciruela, Francisco ;
Borycz, Janusz ;
Solinas, Marcello ;
Quarta, Davide ;
Antoniou, Katerina ;
Quiroz, Cesar ;
Justinova, Zuzana ;
Lluis, Carme ;
Franco, Rafael ;
Goldberg, Steven R. .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 :2391-2399
[14]  
Fredholm BB, 1999, PHARMACOL REV, V51, P83
[15]   POTENTIATION OF COCAINE DISCRIMINATIVE EFFECTS BY CAFFEINE - A TIME-EFFECT ANALYSIS [J].
GAUVIN, DV ;
CRIADO, JR ;
MOORE, KR ;
HOLLOWAY, FA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (01) :195-197
[16]   Caffeine metabolism, genetics, and perinatal outcomes: A review of exposure assessment considerations during pregnancy [J].
Grosso, LM ;
Bracken, MB .
ANNALS OF EPIDEMIOLOGY, 2005, 15 (06) :460-466
[17]   Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist [J].
Halldner, L ;
Lozza, G ;
Lindström, K ;
Fredholm, BB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (03) :345-354
[18]   The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion:: a study in mice lacking adenosine A1 and/or A2A receptors [J].
Halldner, L ;
Ådén, U ;
Dahlberg, V ;
Johansson, B ;
Ledent, C ;
Fredholm, BB .
NEUROPHARMACOLOGY, 2004, 46 (07) :1008-1017
[19]   LONG-TERM CONSEQUENCES OF PRENATAL EXPOSURE TO COCAINE OR RELATED DRUGS - EFFECTS ON RAT-BRAIN MONOAMINERGIC RECEPTORS [J].
HENDERSON, MG ;
MCCONNAUGHEY, MM ;
MCMILLEN, BA .
BRAIN RESEARCH BULLETIN, 1991, 26 (06) :941-945
[20]   Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease [J].
Henry, B ;
Crossman, AR ;
Brotchie, JM .
EXPERIMENTAL NEUROLOGY, 1998, 151 (02) :334-342